🦶
Diabetic Foot — Complex Procedures & Limb Salvage
Diabetic foot complications are the leading cause of non-traumatic amputation in India — and most are preventable. Dr. Sidhu manages the full spectrum: from early neuropathic ulcers to severe infected wounds with bone involvement (osteomyelitis), wet gangrene, and cases referred for amputation from other centres.
Her approach combines aggressive wound debridement, advanced dressings, wound vacuum-assisted closure (VAC), vascular assessment (ABI, Doppler), and simultaneous intensive blood sugar control. Cases that arrive with "no option but amputation" are reassessed systematically — and in the majority, the limb is saved.
Procedures performed: surgical debridement, wound VAC, minor amputations to preserve maximum function, stem cell application, split-thickness skin grafting coordination.
🧬
Stem Cell Therapy for Diabetic Foot
Stem cell therapy is one of the most significant advances in diabetic foot treatment of the past decade. For patients with poor blood flow to the feet — where wounds cannot heal because circulation is inadequate — stem cells injected into the affected limb stimulate new blood vessel formation (angiogenesis), restoring the circulation that healing requires.
Dr. Sidhu uses autologous stem cell therapy (cells derived from the patient's own bone marrow or peripheral blood) — avoiding rejection risk while harnessing the body's own regenerative capacity. This approach has saved limbs in patients who had exhausted all other options. Not every patient qualifies — detailed vascular and haematological assessment determines eligibility. Dr. Sidhu discusses realistic expectations with every patient before proceeding.
🩸
Type 1 Diabetes — Expert Management
Type 1 diabetes requires a fundamentally different clinical mindset from Type 2. It is an autoimmune condition, not a lifestyle disease — and it demands insulin therapy from day one, complex dose adjustment, and intensive patient education that most endocrinology services in India do not provide adequately.
Dr. Sidhu has deep expertise in Type 1 diabetes management: initiating and optimising insulin regimens (basal-bolus, insulin pump therapy), interpreting continuous glucose monitor (CGM) data, teaching carbohydrate counting, managing sick day rules, and — critically — preventing and managing DKA. She provides structured education programmes for newly diagnosed Type 1 patients and their families, recognising that knowledge is the most powerful tool in managing this condition.
🚨
DKA — Prevention, Emergency Management & Education
Diabetic ketoacidosis (DKA) is a life-threatening emergency that kills thousands of Indians every year — most of them young Type 1 diabetic patients who didn't recognise the warning signs, or who didn't have access to emergency care that could manage it correctly.
Dr. Sidhu is highly experienced in DKA emergency management — the precise fluid replacement, insulin protocols, electrolyte replacement, and monitoring that determines outcomes in the critical first 12–24 hours. But her focus is equally on prevention: structured education programmes teaching patients to recognise early DKA, sick day rules, when to check ketones, and when to seek emergency care before it becomes critical. A prevented DKA episode is always better than a treated one.
Gini's DKA survival rate: 98% — significantly above the 85% national average — reflecting both the emergency management capability and the preventive education Dr. Sidhu provides.
💊
GLP-1 Therapy — Weight Loss & Diabetes Control
GLP-1 receptor agonists (Mounjaro/tirzepatide, Ozempic/semaglutide, Wegovy) represent the most significant advance in diabetes and obesity medicine in a generation. Dr. Sidhu prescribes and manages GLP-1 therapy as part of Gini's comprehensive programme under Dr. Bhansali's clinical leadership.
Her approach: full metabolic assessment before starting (HbA1c, fasting insulin, HOMA-IR, lipid profile, kidney function, thyroid), drug and dose selection based on the patient's specific metabolic profile (Mounjaro tends to produce greater weight loss; semaglutide has the strongest cardiac outcome evidence), careful titration to minimise side effects, and monthly monitoring with dose adjustment based on real-world response. She also counsels patients on the lifestyle changes that maximise GLP-1 outcomes and on the long-term commitment that the therapy requires.
📚
Diabetes Education & Counselling
Diabetes is the only major chronic disease where the patient makes dozens of clinical decisions every day — what to eat, whether to adjust insulin, how to interpret a glucose reading, what to do when sick. The quality of those decisions depends entirely on the quality of their education.
Dr. Sidhu provides structured diabetes education for newly diagnosed patients (both Type 1 and Type 2), patients starting insulin, patients with recurrent hypoglycaemia or DKA, and patients struggling with control despite medication. Her sessions cover: understanding glucose patterns, carbohydrate counting, insulin adjustment, hypoglycaemia recognition and treatment, sick day rules, and foot care. For Type 1 patients and families — particularly children and young adults — she provides extended education programmes that empower genuine self-management.
